Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on September 1, 2026

Sep. 1, 2026

Satellos to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Kymera Therapeutics Announces Presentations on KT-621, a First-in-Class, Oral STAT6 Degrader, at the European Respiratory Society and European Academy of Dermatology & Venereology Congresses

Indeterminate GlobeNewswire

Sep. 1, 2026

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

Sep. 1, 2026

Harrow to Participate in Three Investor Conferences in September 

Indeterminate GlobeNewswire

Sep. 1, 2026

Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP

Indeterminate GlobeNewswire

Sep. 1, 2026

RISE Robotics Awarded $100,000 MassVentures Grant to Accelerate Commercialization of Beltdraulic Technology

Indeterminate GlobeNewswire

Sep. 1, 2026

Skipio Acquires RapidTalk to Expand AI-Powered Customer Engagement

Indeterminate GlobeNewswire

Sep. 1, 2026

HealthTab™ Programme Expands Nationally Across England

Indeterminate GlobeNewswire

Sep. 1, 2026

New Engen Named to ADWEEK’s Fastest Growing Agencies for Fourth Consecutive Year

Indeterminate GlobeNewswire

Sep. 1, 2026

OwlTing Group (NASDAQ: OWLS) Reports OwlPay Harbor August Payment Volume Nearly Tripled Month Over Month

Indeterminate GlobeNewswire

Sep. 1, 2026

Optivate Completes Rollout of AI Documentation Suite with Launch of AI Scribe Pro

Indeterminate GlobeNewswire

Sep. 1, 2026

BICEL™ SOFT TIP I/A terralution™. Gentle by Design. Sustainable by Nature*.

Indeterminate GlobeNewswire

Sep. 1, 2026

Boehringer Ingelheim launches SCOVELLA® in Great Britain, the first approved therapy for insulin dysregulation in horses, a main cause of laminitis

Indeterminate GlobeNewswire

Sep. 1, 2026

ENA Respiratory Awarded Biointelect Venturer Funding to Support New Study in Asthma Patients of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

Indeterminate GlobeNewswire

Sep. 1, 2026

Resolution Therapeutics partners with the Blood Centers of America, Inc. to support broad patient access to its experimental Regenerative Macrophage Therapy in the U.S.

Indeterminate GlobeNewswire

Sep. 1, 2026

NewHydrogen Files Third Patent to Protect Its Breakthrough Technology

Indeterminate GlobeNewswire

Sep. 1, 2026

Global Insured Catastrophe Losses Now Expected to Average $171 Billion Annually, Verisk Finds

Indeterminate GlobeNewswire